Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.56 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27152670 | 0.95 | CYP4F2 (0.51) | CYP4F2CYP4A11LMNAHSD17B10MEN1 | |
| SCHEMBL524287 | 0.83 | CYP4F2 (0.51) | CYP4F2CYP4A11LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL18261781 | 0.83 | CYP4F2 (0.54) | CYP4F2CYP4A11LMNAHSD17B10ACHE | |
| SCHEMBL500120 | 0.81 | CYP4F2 (0.61) | CYP4F2CYP4A11ACHEMEN1MAPT | |
| SCHEMBL2461067 | 0.78 | CYP4F2 (0.43) | CYP4F2CYP4A11LMNAMEN1MAPT | |
| SCHEMBL5557393 | 0.78 | CYP4F2 (0.72) | CYP4F2CYP4A11LMNAHSD17B10MEN1 | |
| SCHEMBL31150688 | 0.78 | CYP4F2 (0.67) | CYP4F2CYP4A11ACHEATM | |
| SCHEMBL30872526 | 0.78 | CYP4F2 (0.53) | CYP4F2CYP4A11MEN1MAPTKMT2A | |
| Ethylene Glycol SCHEMBL2229967 | 0.77 | CYP4F2 (0.39) | CYP4F2CYP4A11 | |
| SCHEMBL28713995 | 0.77 | CYP4F2 (0.50) | CYP4F2CYP4A11LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 971 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| WO-2026041853-A1 | ECTOPARASITICIDAL COMPOSITION | Red E Med Limited (GB) | 2026-02-26 | — | — | WO | claimed |
| EP-4688908-A2 | CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4688909-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONO-CARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250281376-A1 | Hair Care Composition | CORET JOEL MARCEL (US) | 2025-09-11 | — | — | US | claimed |
| US-20250268804-A1 | FRAGRANCE COMPOSITIONS | FIRMENICH SA (CH) | 2025-08-28 | — | — | US | claimed |
| EP-4578511-A1 | LIQUID OILY COMPOSITION, AND COSMETIC MATERIAL CONTAINING LIQUID OILY COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2025-07-02 | — | — | EP | claimed |
| WO-2025137392-A1 | CONDITIONER COMPOSITIONS, CLEANSER COMPOSITIONS AND METHODS OF USING THE SAME | K18, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250170047-A1 | LIQUID OILY COMPOSITION, AND COSMETIC MATERIAL CONTAINING LIQUID OILY COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2025-05-29 | — | — | US | claimed |
| EP-2187859-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | Arizona Chemical Company (US) | 2010-05-26 | — | — | EP | claimed |
| WO-2009039158-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY (US) | 2009-03-26 | — | — | WO | claimed |
| US-20090074685-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY, LLC | 2009-03-19 | — | — | US | claimed |
| EP-1765260-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | Brown, Steven J. (US) | 2007-03-28 | — | — | EP | claimed |
| US-20060204460-A1 | Lip gloss composition | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2006-09-14 | — | — | US | claimed |
| WO-2006085907-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | BROWN STEVEN J (US) | 2006-08-17 | — | — | WO | claimed |
| US-20050271595-A1 | Sanitizing composition and method of preparation | BROWN JAMES S | 2005-12-08 | — | — | US | claimed |
| EP-0861657-B1 | Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose | OREAL (FR) | 2005-11-30 | — | — | EP | claimed |
| US-5908631-A | ETHYLCELLULOSE IS SUBSTANTIALLY SOLUBILIZED IN AT LEAST ONE SOLVENT WHICH MAY BE A NATURAL OIL, A TRIGLYCERIDE, A PROPYLENE GLYCOL ESTER, A NEOPENTYL GLYCOL ESTER, A FATTY ALCOHOL OR MIXTURES THEREOF. | L'OREAL S.A. (FR) | 1999-06-01 | — | — | US | claimed |
| EP-0861657-A2 | Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose | L'Oreal S.A. (FR) | 1998-09-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | CYP4F2 1439/4885CYP4A11 1247/4885LMNA 1256/4885 |
| US-20250268804-A1 | FRAGRANCE COMPOSITIONS | PLIN5, ELOVL5, ALOX5 | CYP4F2 1248/4885CYP4A11 2803/4885LMNA 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.